Espervita Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 8

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 23

Loading Chart...

6 inventors (with patents filed for the assignee):

Daniela Carmen Oniciu (8 out of 16 patents)

Jaya Gautam (2 out of 2 patents)

James Stuart Vincent Lally (2 out of 2 patents)

4. Roger Schofield Newton (2 out of 2 patents)

5. Spencer Heaton (2 out of 2 patents)

6. Gregory R Steinberg (2 out of 2 patents)

8 patents: Sort by Forward Citations

1. 12396972 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease (2025-08-26),

2. 12252467 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease (2025-03-18),

3. 12180151 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease (2024-12-31),

4. 11737995 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease (2023-08-29),

5. 11730712 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease (2023-08-22),

6. 11267778 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease (2022-03-08),

7. 11098002 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease (2021-08-24),

8. 11084773 - Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of disease (2021-08-10),

Company Overview

Espervita Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for neurological and psychiatric disorders. The company's cutting-edge research and development efforts aim to address the unmet medical needs of patients with conditions such as Alzheimer's disease, schizophrenia, and depression. Espervita Therapeutics is committed to advancing the field of neuroscience through the discovery of novel treatments that have the potential to improve the quality of life for millions of people worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#11 in Saline, MI

#1,236 in Michigan

#35,951 in US

Saline, MI, United States of America

Espervita Therapeutics, Inc.

Forward Citations = 23

6 inventors:

Daniela Carmen Oniciu (8 out of 16 patents)

Jaya Gautam (2 out of 2 patents)

James Stuart Vincent Lally (2 out of 2 patents)

4. Roger Schofield Newton (2 out of 2 patents)

5. Spencer Heaton (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Espervita Therapeutics, Inc.. Retrieved from https://idiyas.com/company/espervita-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]